0
0

Reversing the Youth Tobacco Epidemic Act of 2020

2/8/2022, 11:22 PM

Congressional Summary of S 3174

Reversing the Youth Tobacco Epidemic Act of 2019

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

  • requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
  • requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
  • prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
  • prohibits flavors other than tobacco in a tobacco product;
  • prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
  • increases the user fees that the FDA collects from manufacturers and importers;
  • directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco);
  • establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities;
  • increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
  • requires the Government Accountability Office to study e-cigarettes.  

Current Status of Bill S 3174

Bill S 3174 is currently in the status of Bill Introduced since January 9, 2020. Bill S 3174 was introduced during Congress 116 and was introduced to the Senate on January 9, 2020.  Bill S 3174's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 9, 2020

Bipartisan Support of Bill S 3174

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
12
Democrat Cosponsors
12
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3174

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures
- Child health
- Civil actions and liability
- Congressional oversight
- Consumer affairs
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug, alcohol, tobacco use
- Food and Drug Administration (FDA)
- Government information and archives
- Government studies and investigations
- Health care coverage and access
- Health programs administration and funding
- Health promotion and preventive care
- Marketing and advertising
- Mental health
- Minority health
- Racial and ethnic relations
- Retail and wholesale trades
- State and local government operations
- User charges and fees

Alternate Title(s) of Bill S 3174

Reversing the Youth Tobacco Epidemic Act of 2020
Reversing the Youth Tobacco Epidemic Act of 2020
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.

Comments